| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/14/2007 | CA2631231A1 Therapeutic agent for corneal/conjuctival disease |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1320383B1 Photosensitisers |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | CN1977894A Medicinal composition with anti-inflammation effect and its preparing method |
| 06/13/2007 | CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 06/13/2007 | CN1321112C Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 06/13/2007 | CN1320928C Eye drops |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230032 Calcium blockers to treat proliferative vitreoretinopathy |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230028 Dimeric compounds and their use as anti-viral agents |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2122340C Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| 06/07/2007 | WO2007065021A2 A predictive tool for hyaluronidase treatment success |
| 06/07/2007 | WO2007064543A1 Hyaluronic acid and hyaluronidase in the enhancement of lens regeneration |
| 06/07/2007 | WO2006122249A3 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 06/07/2007 | US20070129418 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye |
| 06/07/2007 | US20070129404 kinase enzyme inhibitor 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, useful as a drug treating eye diseases including glaucoma |
| 06/07/2007 | US20070129397 Ester derivatives |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/06/2007 | EP1792994A2 Vaccines of bacterial outer membrane vesicles |
| 06/06/2007 | EP1791835A2 Thiazole derivatives having vap-1 inhibitory activity |
| 06/06/2007 | EP1791568A2 Therapeutic uses of inhibitors of rtp801 |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1496894A4 Angiogenesis inhibitors |
| 06/06/2007 | EP1406637B1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 06/06/2007 | EP1158958B1 Improved powdery pharmaceutical compositions for inhalation |
| 06/06/2007 | CN1976694A Topical formulations for treating allergic diseases |
| 06/06/2007 | CN1976692A Methods and compositions for treating ophthalmic conditions with retinyl derivates |
| 06/06/2007 | CN1973873A Eye health food capsule |
| 06/06/2007 | CN1319968C Compositions useful as inhibitors of GSK-3 |
| 06/06/2007 | CN1319950C 3-substituted-4-pyrimidone derivatives |
| 06/06/2007 | CN1319597C Polysaccharide-containing compositions and use thereof |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders |
| 06/05/2007 | US7226972 Cosmetics, drugs |
| 06/05/2007 | US7226934 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 06/05/2007 | US7226924 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use |
| 06/05/2007 | US7226614 segmented; sustained release; for treatment of allergies |
| 06/05/2007 | CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/05/2007 | CA2214431C Human vegf-specific antisense oligonucleotides |
| 05/31/2007 | WO2007061200A1 Composition having effect on treatment and prevention of dry eye syndrome |
| 05/31/2007 | WO2007061094A1 Pharmaceutical comprising ppar agonist |
| 05/31/2007 | WO2007060458A2 Treatment of ophthalmic diseases with beta-amino alcohols |
| 05/31/2007 | WO2007060028A1 Napthyridine compounds as rock inhibitors |
| 05/31/2007 | WO2007037554A9 Adsorbent for advanced glycation endproducts |
| 05/31/2007 | WO2006110496A3 Activation of sodium potassium atpase |
| 05/31/2007 | WO2006062731A8 Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070122508 Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
| 05/31/2007 | US20070122424 Peptide-based vaccine for influenza |
| 05/31/2007 | CA2631408A1 Composition having effect on treatment and prevention of dry eye syndrome |
| 05/31/2007 | CA2630816A1 Pharmaceutical comprising ppar agonist |
| 05/31/2007 | CA2593718A1 Napthyridine compounds as rock inhibitors |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790641A1 Triazole derivative or salt thereof |
| 05/30/2007 | EP1790353A1 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1790340A2 Combination chemotherapy |
| 05/30/2007 | EP1790338A1 Therapeutic agent for keratoconjunctiva disorder |
| 05/30/2007 | EP1538888A4 Upper hitch link |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1180103B1 Renin inhibitors |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | CN1972714A Methods of treating autoimmune and inflammatory diseases |
| 05/30/2007 | CN1972677A Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 05/30/2007 | CN1970039A Medicated wine for treating myopia, hyperopia, astigmatism and presbyopia |
| 05/30/2007 | CN1318446C Transferrin receptor protein of Moraxella |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |